Background: Solid pseudopapillary neoplasms (SPN) of the pancreas are rare pancreatic neoplasms where complete resection is the cornerstone in management. It has been demonstrated in previous studies that minimally invasive surgical approaches are effective management options in treating SPNs of the distal pancreas. The purpose of this study is to evaluate the feasibility of minimally invasive surgery in treating SPNs of the uncinate, head, and neck of the pancreas. Methods: Data from 2005 to 2017 at Severance Hospital of the Yonsei University Health systems in Seoul, South Korea, were retrospectively collected for 25 patients who were diagnosed with SPN of the uncinate, head, and neck of the pancreas and who underwent curative resection. Three groups of patients were considered, depending on the year of surgery, in order to determine trends in the surgical management of SPN. The patients were also divided into two groups corresponding to the type of operation done (minimally invasive surgery vs. open surgery). Perioperative patient data, including age, gender, body mass index (BMI), tumor size, and operation done, were compared and analyzed statistically. Long-term nutritional effects were measured using the Controlling Nutritional Status (CONUT) scoring system. Results: There were no statistically significant differences in age, gender, BMI, symptomatic presentation, operation type, tumor size, and tumor stage between the three time periods. In comparing between minimally invasive and open surgery, there were no statistically significant differences in age, gender, symptomatic presentation, BMI, tumor size, preoperative stage, type of operation, operation time, pancreatic duct size, post-operative pancreatic fistula (POPF) grade, death associated with disease, recurrence, pathological parameters, and change in CONUT score. There was a significant difference in tumor size (4.5 ± 1.8 vs. 2.6 ± 1.0 cm, p = 0.004), blood loss (664.2 ± 512.4 vs. 277.7 ± 250.8 mL, p = 0.024), need to transfuse (33% vs. 0%, p = 0.023), hospital length of stay (27.4 ± 15.3 vs. 11.5 ± 5.3 days, p = 0.002), and complication rate (75% vs. 30.8%, p = 0.027) between the two groups. Conclusions: In appropriately selected patients with SPNs of the uncinate, head, and neck of the pancreas, a minimally invasive surgical approach offers at least equal oncologic and nutritional outcomes, while demonstrating decreased complications and decreased hospital length of stay compared with that of an open surgical approach.
Background
Neoplasms of the pancreas are the fourth most common cause of cancer-related death globally [1] . These tumors are often difficult to detect due to their location; most patients present with non-specific symptoms or clinicians discover them on incidental radiographs for different conditions [2, 3] . Solid pseudopapillary neoplasm (SPN) of the pancreas, also referred to as Frantz's tumor, is rare, comprising 1-2% of all pancreatic tumors [4] [5] [6] . SPNs of the pancreas are usually diagnosed in females who are in their third to fourth decade of life and this tumor carries a good prognosis, with a 5-year survival rate of up to 97% [6] [7] [8] [9] . SPN is considered to be a tumor with low malignant potential; however, up to 10-15% of cases have been reported to be aggressive and can metastasize to the liver and/or peritoneum [10] . Despite its malignant potential, resections with no microscopically detected cancer cell at the resection margin (R0) and en bloc resections have been reported to improve overall survival and disease-free survival [11, 12] .
The distal pancreas is the most common site of occurrence, but with advancements in imaging techniques and practices, SPNs located at the uncinate, head, and neck of the pancreas, referred collectively henceforth as the proximal pancreas, are now being increasingly reported [9, 13] . A previous study compared the outcomes of minimally invasive (MI) and open distal pancreatectomies in patients with SPN where the outcome favored minimally invasive surgical approaches (laparoscopic and robot-assisted) [14] . As such, the need to investigate surgical approaches for SPNs of the proximal pancreas is needed in order to provide the surgeon with viable options in the management of all SPNs of the pancreas.
Therefore, the purpose of this study was to compare the perioperative short-term and long-term outcomes of minimally invasive (laparoscopic and robotic) and open surgical approaches of the proximal pancreas in patients with pathologically confirmed SPNs.
Methods

Data collection
Patients' medical records were retrospectively reviewed to identify those who underwent either open or MI pylorus-preserving pancreaticoduodenectomy (PPPD), classic Whipple procedure (PD), or central pancreatectomy (CP) for pathologically confirmed SPNs between 2006 and 2017 at the Severance Hospital of the Yonsei University Health System in Seoul, South Korea. Data representing the clinicopathological characteristics, such as age, gender, tumor size, and location, were retrospectively collected. Patients who underwent extensive surgeries or combined resections were excluded from this study in order to avoid selection bias in the comparative analysis between MI and open surgical approaches.
For the assessment of long-term nutrition, the Controlling Nutritional Status (CONUT) scoring system was used. The CONUT score utilizes serum albumin, cholesterol, and total lymphocyte count as parameters to measure the nutritional status of patients and has been shown to be predictive of survival in colorectal neoplasms [15, 16] and hepatocellular neoplasms [17] . We stratified the study population into three groups according to the year when the surgery was performed (e.g., 2006-2009, 2010-2013, 2014-2017) 
Results
Chronological changes of clinical characteristics according to period
From 2006 to 2017, 98 patients underwent surgery for SPN at the Severance Hospital of the Yonsei University Health Systems. Of the 98 patients, 25 were diagnosed with SPN at the proximal pancreas and were included in this study. There were no statistical differences in the age, gender, BMI, and symptoms across the three periods (Table 1) . There was an increasing trend of patients undergoing minimally invasive procedures from the first time period up to the third time period; however, this was not statistically significant (p = 0.269). Moreover, the neoplasm stage at presentation was not statistically significant; however, it was noted that the size of tumors was smaller during the period from 2014 to 2017 compared to the period from 2010 to 2013.
General patient characteristics
Of the 25 patients included in this study, 22 were female and three were male (female to male ratio was 7.3:1). On average, the patients were 38.2 ± 14.3 years old and had a BMI of 22.4 ± 2.58 kg/m 2 . Additionally, the mean tumor size was 3.51 ± 1.72 cm with a mean Table 2 ). All patients underwent an R0 resection and all remnant pancreata were described to be soft on palpation. In contrast, tumor size, blood loss, need for transfusion, hospital length of stay, and complication incidence were significantly greater in open surgery compared to MI surgery (p ≤ 0.027 for all).
Histopathologic outcomes
We compared the histopathologic outcomes of the patients based on their surgical approach. The collected data is presented in Table 3 . During the follow-up period (median, 57 months; range, 4-120 months), none of the patients in this study experienced tumor recurrence or death as a result of the disease. All pathologic resection margins were negative for disease. Further, a review of the microscopic pathologic parameters (capsular invasion, lymphovascular invasion, perineural invasion), as well as the post-operative stage, revealed that there were no significant differences between the surgical approaches.
Long-term nutritional assessment
The CONUT scoring system was used to determine the nutritional status of patients prior to surgery and 6 and 12 months after surgery. Nearly all of the patients had improvements, and none experienced worsening, in nutritional status (Table 4) . No significant changes in nutritional status were detected between the surgical approaches at 6 and 12 months after surgery (p > 0.05 for all, Table 4 ).
Discussion
In a previous study, we have reported the surgical outcomes of minimally invasive distal pancreatectomy for SPN of the pancreas [14] . There are also several literatures reported [18] [19] [20] [21] [22] showing favorable perioperative outcomes in managing SPN of the distal pancreas; however, minimally invasive surgical procedures (PPPD or CP) for SPN in the proximal pancreas seems rare.
Patients who underwent open or MI surgeries for SPN at the proximal pancreas showed no statistically significant differences in terms of gender, age, BMI, pancreas characteristics, operation time, and American Joint Committee on Cancer (AJCC) cancer stage. However, it was demonstrated that patients with MI surgery had a smaller tumor size at presentation (mean, 2.6 vs. 4.5 cm, respectively), which may have been a factor in deciding which surgical approach to perform in managing SPN of the proximal pancreas.
The study results showed statistically significant differences in length of hospital stay, complication incidence, blood loss, and transfusion requirement, all of which favored the MI surgical approach. These [24] . It should also be noted that there was no residual tumor after the operation and that all pathological reports indicated margin-free tumors in all cases. This entails that both open and MI surgical approaches can deliver comparable long-term results that are within the oncologic parameters.
The role of nutrition in improving perioperative outcomes is being recognized increasingly. Several researches describe decreased complications, as well as improved surgical outcomes, as a direct effect of improving the perioperative nutritional status of the patient [25] [26] [27] [28] . Our study noted that there was an improvement in the CONUT score of nearly all of the patients at 6 and 12 months after surgery. However, there was no statistical difference in the change of nutritional status between the surgical approaches (p < 0.05). This implies that both open and MI surgical approaches can achieve quality of life goals in managing patients with SPN.
Conclusion
The current first-line treatment for SPN of the pancreas remains to be complete excision. Studies have shown that complete excision can increase overall survival and disease-free survival. However, as with all surgical encounters, we must balance these maximal oncologic practices with minimizing complications and potential adverse outcomes. This study suggests that in appropriately selected patients with SPNs located at the uncinate, head, or neck of the pancreas, a MI surgical approach offers at least comparable oncologic outcomes as an open approach, while demonstrating decreased complications and decreased hospital length of stay. We recommend that a larger comparison be conducted in order to strengthen this conclusion. 
